CVS Health Corp. (CVS) Stock Score, Valuation & Financial Research
CVS Health Corp. is in the Healthcare sector and Medical - Healthcare Plans industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 31/100.
Quick answer for CVS
CVS Health Corp. currently has a Wall Street Score of 31/100. The stored market price is $91.72. Its financial score is 33/100. Its valuation score is 16/100. The latest WSS change is +0.3 points. These figures are a research snapshot, not a buy or sell recommendation.
What CVS Health Corp. does
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS financial snapshot
- Wall Street Score:
- 31/100
- Current price:
- $91.72
- Market capitalization:
- $117.03B
- Revenue:
- $415.09B
- Net income:
- $4.91B
- Free cash flow:
- $7.81B
- Cash:
- $11.33B
- Total debt:
- $76.31B
- EPS:
- 3.83
- P/E ratio:
- 23.9x
- Financial score:
- 33/100
- Valuation score:
- 16/100
- Revenue score:
- 33/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $7.81B, showing positive cash generation.
- The balance sheet shows $11.33B of cash versus $76.31B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.3 points: CVS increased 0.3 points because Capital improved by 2 points.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 33/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-17.
How to research CVS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.